| Sep 26 |
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
| Sep 24 |
Here's Why We're Not At All Concerned With Belite Bio's (NASDAQ:BLTE) Cash Burn Situation
|
| Sep 17 |
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
|
| Sep 10 |
Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
|
| Sep 3 |
Belite Bio to Participate in Three Upcoming Investor Conferences
|
| Sep 3 |
Belite Bio names Hendrik P. N. Scholl as chief medical officer
|
| Sep 1 |
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
|
| Aug 13 |
Belite Bio GAAP EPS of -$0.26 in-line
|
| Aug 13 |
Belite Bio, Inc 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 13 |
Belite Bio, Inc (BLTE) Q2 2024 Earnings Call Transcript
|
